← Browse by Condition
Medical Condition

pulmonary rehabilitation

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for pulmonary rehabilitation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pulmonary rehabilitation Clinical Trials

How many clinical trials are currently recruiting for pulmonary rehabilitation?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for pulmonary rehabilitation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pulmonary rehabilitation?
pulmonary rehabilitation research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pulmonary rehabilitation clinical trial?
Eligibility criteria for pulmonary rehabilitation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Saglik Bilimleri Universitesi 2 trials
Istanbul Medipol University Hospital 1 trial
Universita degli Studi di Genova 1 trial

Recruiting Clinical Trials

NCT03561818
Recruiting
Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis
Enrollment
50 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul Medipol University Ho...
View Trial →
NCT07093125
Recruiting
Rehabilitation Practices in Critically Ill Patients Receiving Invasive Mechanical Ventilation in the Intensive Care Unit.
Enrollment
2,400 pts
Location
Italy
Sponsor
Universita degli Studi di Geno...
View Trial →
NCT06998550
Recruiting
Patient Experiences and the Role of Team Structures in Pulmonary Rehabilitation in Türkiye
Enrollment
384 pts
Location
Turkey (Türkiye)
Sponsor
Saglik Bilimleri Universitesi
View Trial →
NCT06848608
Recruiting
Comparison of the Effects of Yoga and Conventional Physiotherapy Programs in Sarcoidosis
Enrollment
32 pts
Location
Turkey (Türkiye)
Sponsor
Saglik Bilimleri Universitesi
View Trial →

Related Conditions

bronchiectasis (1) lung diseases (1) lung diseases interstitial (1) mechanical ventilation (1) intensive care units icus (1) quality of life qol (1) outcome assessment (1) extubation failure (1) mortality (1) critical care (1) pulmonary disease (1) sarcoidosis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology